BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35383004)

  • 21. Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.
    Zheng P; Chen Q; Li J; Jin C; Kang L; Chen D
    J Surg Res; 2020 Jan; 245():475-482. PubMed ID: 31446189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.
    Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
    Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer.
    Miyoshi Y; Noguchi K; Yanagisawa M; Taguri M; Morita S; Ikeda I; Fujinami K; Miura T; Kobayashi K; Uemura H
    BMC Cancer; 2015 May; 15():338. PubMed ID: 25929438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.
    Budnik J; Suri J; Bates JE; Bylund KC; Milano MT
    Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
    Wan L; Tu C; Li S; Li Z
    Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?
    Janssen SJ; van der Heijden AS; van Dijke M; Ready JE; Raskin KA; Ferrone ML; Hornicek FJ; Schwab JH
    Clin Orthop Relat Res; 2015 Oct; 473(10):3112-21. PubMed ID: 26155769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional location of lymph node metastases predicts survival in patients with
    Wang ZP; Chen JR; Zhao JG; Zhu S; Zhang XM; Liang JY; He B; Ni YC; Sun GX; Shen PF; Zeng H
    Asian J Androl; 2023; 25(4):462-467. PubMed ID: 36348577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients.
    Rii J; Sakamoto S; Yamada Y; Takeshita N; Yamamoto S; Sazuka T; Imamura Y; Nakamura K; Komiya A; Komaru A; Fukasawa S; Nakatsu H; Akakura K; Ichikawa T
    Prostate; 2020 Aug; 80(11):850-858. PubMed ID: 32501559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
    Whitney CA; Howard LE; Posadas EM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
    Eur Urol Focus; 2017 Oct; 3(4-5):480-486. PubMed ID: 28753787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.
    Wang S; Yu Y; Xu W; Lv X; Zhang Y; Liu M
    BMC Cancer; 2021 Aug; 21(1):653. PubMed ID: 34344326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
    Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
    Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
    Hanyok BT; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Posadas EM; Freedland SJ
    Cancer; 2016 Jan; 122(2):222-9. PubMed ID: 26484853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate Cancer.
    Daskivich TJ; Luu M; Freedland SJ; Sandler H; Spratt DE; Zumsteg ZS
    J Urol; 2022 Mar; 207(3):581-591. PubMed ID: 34694160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.
    Gao B; Wang MD; Li Y; Huang F
    Front Public Health; 2022; 10():949500. PubMed ID: 35991065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.
    Moschini M; Sharma V; Zattoni F; Quevedo JF; Davis BJ; Kwon E; Karnes RJ
    Eur Urol; 2016 Jan; 69(1):135-42. PubMed ID: 25865061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
    Huang X; Hu P; Yan F; Zhang J
    Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
    Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
    Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
    Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
    Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumors.
    Wu Y; Meyers JP; Shi G; Jin Z; Xia J; Gu Y; Qian Q; Hong Y
    J Surg Oncol; 2019 Sep; 120(3):508-517. PubMed ID: 31140623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive assessment of the prognostic utility of the Stephenson nomogram for salvage radiation therapy postprostatectomy.
    Johnson S; Jackson W; Speers C; Feng F; Hamstra D
    Pract Radiat Oncol; 2014; 4(6):422-9. PubMed ID: 25407865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.